FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Trial Enrichment Strategies Guidance

FDA publishes a guidance to help drug trial sponsors develop enrichment strategies that can be used to demonstrate drug and biological product effecti...

Federal Register

Info Collection Extension for Accredited Person Inspections

Federal Register notice: FDA seeks comments on an information collection extension for Inspection by Accredited Persons Program Under the Medical Devi...

Federal Register

FDA Updates Modifications to the List of Recognized Standards

Federal Register notice: FDA posts an updated Modifications to the List of Recognized Standards, Recognition List Number: 051.

Human Drugs

Info Collection Extension for PET Imaging Drugs

Federal Register notice: FDA seeks comments on an information collection extension for Current Good Manufacturing Practice (CGMP) for Positron Emissio...

Human Drugs

Hematologic Disorder Drug Development Guidance

FDA issues a guidance on design of nonclinical studies to develop pharmaceuticals to treat patients with severely debilitating or life-threatening hem...

Medical Devices

Guidance on Devices with Animal Source Materials

FDA releases an updated guidance on using animal-derived material in medical device manufacturing.

Federal Register

Draft Guide on Cancer Trials Eligibility for HIV Patients

Federal Register notice: FDA makes available a draft guidance entitled Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Viru...

Federal Register

Animal Drug Regs Amended to Reflect Application Actions

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for new animal drug applications and abbreviate...

Human Drugs

2 EIRs Issued to Pharmaceutics International

FDA issues Pharmaceutics International two Establishment Inspection Reports following routine and pre-approval inspections last October and November a...

Medical Devices

Two Biotronik Cardiac Rhythm Devices Approved

FDA approves Biotroniks Acticor and Rivacor high-voltage cardiac rhythm management device lines for treating patients with cardiac arrhythmias.